The island lost power during the storm, and electricity is not expected to be restored for three to six months. Most drug plants in Puerto Rico contain backup power generators, but lack employees to resume operations.
Major drugmakers like Eli Lilly and AstraZeneca are assessing the damage, which could cause national short-term drug shortages if they cannot shift manufacturing capacity to other production sites.
Jennifer Dooren, acting deputy director of operations for the Food and Drug Administration, said the agency coordinated with drug companies before Hurricane Maria “to evaluate the [storm’s] potential.”
“In the aftermath of the storm, we continue to work closely with pharmaceutical companies [that have] manufacturing facilities located in Puerto Rico to prevent shortages of medically necessary drug products,” she said in an email to USA Today.
More articles on supply chain:
OSHA investigates employee death at Amazon warehouse
House Reps. call on Merck to disclose Petya damage, response
AmerisourceBergen commits $100k+ to hurricane relief efforts
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
